Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes.
Fiore A, Ugel S, De Sanctis F, Sandri S, Fracasso G, Trovato R, Sartoris S, Solito S, Mandruzzato S, Vascotto F, Hippen KL, Mondanelli G, Grohmann U, Piro G, Carbone C, Melisi D, Lawlor RT, Scarpa A, Lamolinara A, Iezzi M, Fassan M, Bicciato S, Blazar BR, Sahin U, Murray PJ, Bronte V. Fiore A, et al. Among authors: de sanctis f. Nat Commun. 2018 Dec 5;9(1):5193. doi: 10.1038/s41467-018-07654-4. Nat Commun. 2018. PMID: 30518925 Free PMC article.
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma.
Mazzocco M, Martini M, Rosato A, Stefani E, Matucci A, Dalla Santa S, De Sanctis F, Ugel S, Sandri S, Ferrarini G, Cestari T, Ferrari S, Zanovello P, Bronte V, Sartoris S. Mazzocco M, et al. Among authors: de sanctis f. Immunology. 2015 Sep;146(1):33-49. doi: 10.1111/imm.12477. Epub 2015 Jun 15. Immunology. 2015. PMID: 25959091 Free PMC article.
Targeting tumor vasculature: expanding the potential of DNA cancer vaccines.
Ugel S, Facciponte JG, De Sanctis F, Facciabene A. Ugel S, et al. Among authors: de sanctis f. Cancer Immunol Immunother. 2015 Oct;64(10):1339-48. doi: 10.1007/s00262-015-1747-8. Epub 2015 Aug 13. Cancer Immunol Immunother. 2015. PMID: 26267042 Free PMC article. Review.
Feasibility of Telomerase-Specific Adoptive T-cell Therapy for B-cell Chronic Lymphocytic Leukemia and Solid Malignancies.
Sandri S, Bobisse S, Moxley K, Lamolinara A, De Sanctis F, Boschi F, Sbarbati A, Fracasso G, Ferrarini G, Hendriks RW, Cavallini C, Scupoli MT, Sartoris S, Iezzi M, Nishimura MI, Bronte V, Ugel S. Sandri S, et al. Among authors: de sanctis f. Cancer Res. 2016 May 1;76(9):2540-51. doi: 10.1158/0008-5472.CAN-15-2318. Cancer Res. 2016. PMID: 27197263
Tumor-Induced Myeloid-Derived Suppressor Cells.
De Sanctis F, Bronte V, Ugel S. De Sanctis F, et al. Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.MCHD-0016-2015. Microbiol Spectr. 2016. PMID: 27337449 Free article. Review.
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy.
Sandri S, De Sanctis F, Lamolinara A, Boschi F, Poffe O, Trovato R, Fiore A, Sartori S, Sbarbati A, Bondanza A, Cesaro S, Krampera M, Scupoli MT, Nishimura MI, Iezzi M, Sartoris S, Bronte V, Ugel S. Sandri S, et al. Among authors: de sanctis f. Oncotarget. 2017 May 23;8(50):86987-87001. doi: 10.18632/oncotarget.18115. eCollection 2017 Oct 20. Oncotarget. 2017. PMID: 29152058 Free PMC article.
99 results